UnitedHealth (UNH) Posts $111.62B Q2 Revenue But Earnings Disappoint
UnitedHealth Group Incorporated (NYSE:UNH) stands as one of the largest and most influential healthcare companies in the world,…
Quoin Pharmaceuticals (QNRX) Soars 138% After $104.5M Funding Deal
Quoin Pharmaceuticals Ltd. (NASDAQ:QNRX) is a late clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative therapies…
ARS Pharmaceuticals (SPRY)’s $250M Deal Signals Big Bet on Needle-Free Allergy Treatment
ARS Pharmaceuticals (NASDAQ:SPRY) is a commercial-stage biopharmaceutical company headquartered in San Diego, California, focused on revolutionizing the emergency…
Argenx SE (ARGX) Hits $803.95 All-Time High After 88% Revenue Surge
Argenx NV (NASDAQ:ARGX) is a global immunology biotechnology company founded in 2008 in the Netherlands with a mission…
Universe Pharmaceuticals (UPC) Stock Soars 56%
Universe Pharmaceuticals Inc. (NASDAQ:UPC) is a China-based pharmaceutical company that develops, manufactures, markets, and distributes traditional Chinese medicine…
Turn Therapeutics (TTRX)’s NASDAQ Debut Sends Stock Up 134%
Turn Therapeutics Inc. (NASDAQ:TTRX) is a biotechnology and medical device company founded to revolutionize how therapies are delivered…
Elevance Health (ELV) Down 14.6% YTD
Elevance Health, Inc. (NYSE:ELV) is one of the largest and most influential health insurance and managed care companies…
Teladoc Health (TDOC) Gains 12.5% Analyst Price Target Boost to $9.00
Teladoc Health, Inc. (NYSE:TDOC) is a global leader in virtual healthcare, pioneering a new model of digital-first medicine…
Tarsus Pharmaceuticals (TARS) Skyrockets 10.9% After $181M XDEMVY Sales Surge
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) is a rapidly emerging biopharmaceutical company transforming the eye health industry through first-in-class therapies…
Tempest Therapeutics (TPST) Boosts Cash With $4.6M Raise Ahead of Cancer Trial
Tempest Therapeutics, Inc. (NASDAQ:TPST) is a clinical-stage biotechnology company pioneering dual-action cancer therapies that combine direct tumor targeting…
Regeneron (REGN)’s 68% Efficacy Breakthrough Fails to Impress Wall Street
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the most prominent biotechnology companies in the world, renowned for its…
Wall Street Sees 272% Upside for CRISPR Therapeutics (CRSP) After Historic FDA Win
CRISPR Therapeutics AG (NASDAQ:CRSP) is a leading gene-editing biotechnology company pioneering the use of CRISPR/Cas9 technology to develop…
Candel Therapeutics (CADL) Poised for 272% Upside
Candel Therapeutics, Inc. (NASDAQ:CADL) is a clinical-stage biotechnology company pioneering viral immunotherapies that aim to turn a patient’s…
Xenetic Biosciences (XBIO) Rockets 350%
Xenetic Biosciences (NASDAQ:XBIO) is a Massachusetts-based biopharmaceutical company charting a bold path in immuno-oncology by developing enzyme therapies…
BioHarvest Sciences (BHST) Grows Revenue 58%
BioHarvest Sciences Inc. (NASDAQ:BHST) is a biotechnology company pioneering a new era of sustainable bio-production through its proprietary…
Spruce Bio (SPRB) Jumps 65% — From $34 to $225 Overnight
Spruce Biosciences Inc. (NASDAQ:SPRB) is a late-stage biopharmaceutical company dedicated to developing and commercializing innovative therapies for rare…
NuCana (NCNA) Completes $3.6M Warrant Buyout
NuCana plc (NASDAQ:NCNA) is a clinical-stage biopharmaceutical company headquartered in Edinburgh, Scotland, focused on transforming the treatment landscape…
Galecto (GLTO) Surges 600% Overnight as Traders Swarm the Tiny $5M Biotech
Galecto Inc. (NASDAQ:GLTO) is a clinical-stage biotechnology company dedicated to developing innovative small molecule therapies for fibrosis and…